Optimized Vaccine Development and Manufacturing: A Technology Overview - Certain technology solutions can greatly improve the vaccine manufacturing process. - BioPharm International

ADVERTISEMENT

Optimized Vaccine Development and Manufacturing: A Technology Overview
Certain technology solutions can greatly improve the vaccine manufacturing process.


BioPharm International


19. Kaludov N, et al. Scalable purification of adeno-associated virus type 2, 4, or 5 using ion-exchange chromatography. Human Gene Therapy. 2002;13(10):1235–43.

20. Kalbfuss B. et al. Purification of cell culture-derived human influenza A virus by size-exclusion and anion-exchange chromatography. Biotechnol Bioeng. 2007;96(5):932–944.

21. Novais JL, Titchener-Hooker NJ, Hoare M. Economic comparison between conventional and disposables-based technology for the production of biopharmaceuticals. Biotechnol and Bioengi. 2001;75(2):143–153.

22. Gen Engi news. 2004;24(8).

23. 3rd Annual Report and Survey of Biopharmaceutical Manufacturing, Capacity and Production.

24. Sinclair A, Monge M. Biomanufacturing for the 21st Century: Designing a concept facility based on single-use systems. BioProcess Int. 2004 Oct supp:26–31.


blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

J&J Speeds Ebola Vaccine Development and Expands Production
October 24, 2014
Despite AbbVie Snub, Shire Says it Will Double Sales by 2020
October 24, 2014
Manufacturing Challenges of mAb Production: CHO or Plant Cells?
October 24, 2014
Celgene and Sutro Partner on ADC Development
October 24, 2014
GSK Accelerates Ebola Vaccine Development
October 24, 2014
Author Guidelines
Source: BioPharm International,
Click here